A Genomic Screen for Modifiers of Tauopathy Identifies Puromycin-Sensitive Aminopeptidase as an Inhibitor of Tau-Induced Neurodegeneration-Reference-Cited by-同舟云学术

A Genomic Screen for Modifiers of Tauopathy Identifies Puromycin-Sensitive Aminopeptidase as an Inhibitor of Tau-Induced Neurodegeneration

Published:2006-09 Issue:5 Volume:51 Page:549-560
ISSN:0896-6273
Container-title:Neuron
language:en
Short-container-title:Neuron

Author:

Karsten Stanislav L.,Sang Tzu-Kang,Gehman Lauren T.,Chatterjee Shreyasi,Liu Jiankai,Lawless George M.,Sengupta Soma,Berry Robert W.,Pomakian Justine,Oh Hyun S.,Schulz Cordula,Hui Koon-Sea,Wiedau-Pazos Martina,Vinters Harry V.,Binder Lester I.,Geschwind Daniel H.,Jackson George R.

Publisher

Elsevier BV

Subject

General Neuroscience

Reference69 articles.

1. Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons;Amadoro;Cell Death Differ.,2004

2. Proteolysis of non-phosphorylated and phosphorylated tau by thrombin;Arai;J. Biol. Chem.,2005

3. Polymerization of tau peptides into fibrillar structures. The effect of FTDP-17 mutations;Arrasate;FEBS Lett.,1999

4. Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease;Bancher;Brain Res.,1991

5. The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region;Biernat;EMBO J.,1992

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of endogenous opioid signaling by inhibitors of puromycin-sensitive aminopeptidase;European Journal of Medicinal Chemistry;2024-09

2. Pathogenic tau induces an adaptive elevation in mRNA translation rate at early stages of disease;Aging Cell;2024-06-26

3. Bestatin attenuates breast cancer stemness by targeting puromycin-sensitive aminopeptidase;Discover Oncology;2024-05-30

4. Modulation of endogenous opioid signaling by inhibitors of puromycin sensitive aminopeptidase;2024-04-03

5. NPEPPS Is a Druggable Driver of Platinum Resistance;Cancer Research;2024-03-27